Jiahui Health

What Jiahui Health does

Jiahui Health (嘉会医疗) operates an integrated, JCI-accredited private healthcare ecosystem anchored by a 500-bed tertiary international hospital in Shanghai's Xuhui District and supported by seven outpatient clinics across Shanghai (Yangpu, Jing'an), Suzhou, Hangzhou, Shenzhen, Kunshan, and Hong Kong. The flagship Jiahui International Hospital, opened in 2017 as Shanghai's first government-authorized international hospital, delivers 35+ medical specialties with centers of excellence in oncology (including an international-standard CAR-T cell therapy platform with dedicated laminar-flow wards), reproductive medicine (IVF/ICSI with time-lapse embryo monitoring, 85% fertilization rate), orthopedics and sports medicine, cardiac care, women's and children's health, and executive health screening. Clinical technology includes a Versa HD linear accelerator for advanced radiotherapy, 3.0T MRI, 64-slice CT, interventional oncology platforms (HAIC, TACE, HIPEC), and emerging modalities such as BNCT exploration and solid-tumor CAR-T (CT041/satri-cel).

The company's revenue model blends fee-for-service medical care, subscription-style executive health packages, transaction-fee insurance direct settlement with 50+ commercial insurers (including AIA, AXA, Bupa, Cigna, HSBC Life) plus Shanghai social medical insurance and Huihui Bao coverage for CAR-T, and professional-service international remote consultations with 30+ global partner institutions (MD Anderson, Mayo Clinic, Mass General). Go-to-market is direct B2C through the facility network and international patient services office (multilingual concierge, visa assistance, airport reception), with a cross-border insurance channel and academic-channel referrals reinforced by Harvard/Mass General joint appointments for more than 20% of physicians and the J-MED research and education group.

Founded in 2009, the company is led by Chairman and CMO Ge Feng (项乃强) and CEO-level hospital president Wu Haishan (吴海山), with senior clinical leadership drawn heavily from U.S.-trained, ABIM-certified specialists. A 2015 Series 2 round led by Trustbridge Partners provided growth capital; the company remains private with no parent company, public listing, or M&A disclosed. The organization serves more than 500,000 patient visits annually from 180+ countries and positions itself as Shanghai's flagship international-standard private hospital ecosystem.

Name

Jiahui Health

Legal name

Jiahui, Inc.

Website

https://jiahui.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Jiahui Health operates an integrated private healthcare ecosystem anchored by a 500-bed JCI-accredited international hospital in Shanghai and seven outpatient clinics across eastern China and Hong Kong, delivering tertiary care, oncology, fertility, and executive screening to domestic and international patients.

Ownership category

akta.pro rank

Product category

Private Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Hospital-Based EMS & Mobile Integrated Health (HLAFANAC)

Keywords

• Private hospital network
• Specialty medical centers
• Healthcare services
• Medical oncology care
• Reproductive medicine

Headquarters

HQ city

Xuhui

HQ country

China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive medical services including consultations, diagnostics, treatments, surgeries, hospitalizations, and specialized procedures across all departments and specialties.
2. Insurance Direct Payment: Direct settlement with over 50 insurance companies including international providers, enabling cashless treatment for insured patients. Also includes Shanghai medical insurance (医保) and Huihui Bao (沪惠保) coverage for eligible services including CAR-T therapy.
3. International Remote Consultation Services: Fee-based international teleconsultation services providing second opinions and treatment planning with overseas medical experts for complex cases.
4. Health Screening/Executive Health Management: Preventive health services including comprehensive health assessments, cancer screening, cardiovascular screening, and customized health packages.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Jiahui Health operates an integrated private healthcare ecosystem in China centered on Jiahui International Hospital in Shanghai and a network of specialty centers and outpatient clinics. It provides tertiary hospital services, specialty care in oncology, reproductive medicine, orthopedics, cardiac care, women's and children's health, and executive health screening, supported by international patient services, remote consultation, and direct insurance billing.

Product overview

Jiahui Health is an innovative, integrated healthcare ecosystem anchored by a 500-bed JCI-accredited tertiary international hospital (Jiahui International Hospital, Shanghai), supplemented by a network of general clinics in Shanghai Yangpu, Shanghai Jing'an, Suzhou, Hangzhou, Shenzhen Futian, Kunshan, and Hong Kong. Core clinical products include the Jiahui International Cancer Center (offering chemotherapy, radiotherapy, targeted therapy, immunotherapy, and CAR-T cell therapy), the Reproductive Medicine Center (IVF/ICSI with Time-lapse embryo monitoring), the Health Management Center (executive health screening), and specialty centers in orthopedics, cardiac care, and women's/children's health. The ecosystem also includes international remote consultation and concierge services for overseas patients, and a research/education arm (J-Med). Services are delivered in multiple languages and support insurance direct payment, covering primary care through complex tertiary treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Jiahui International Hospital Tertiary general hospital in Shanghai offering multi-specialty inpatient and outpatient care, affiliated with Harvard Medical School as a teaching hospital.
• Jiahui International Cancer Center (JICC)

Quantifiable outcome

• 85% IVF fertilization rate
• +5 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Eleven partnerships are on record, tiered minor and core.

• Bangkok HospitalminorStrategic or Co-development Partner · 12 February 2026Bangkok Hospital delegation visited Jiahui Health in February 2026 for oncology exchange discussions. Wattanosoth Cancer Hospital Deputy Director Dr. Thianchai Bunnalai and team met with Jiahui leadership to explore collaboration in cancer diagnosis, treatment, and innovation.
• 云知声 (Unisound AI)coreTechnology or Integration · 5 February 2026Strategic partnership signed February 5, 2026 between Jiahui Health and Unisound AI Technology Co., Ltd. Jiahui will leverage Unisound's '山海·知医' medical large language model and full-stack AI technology to develop smart hospital capabilities including AI-powered clinical applications and digital health solutions.
• HSBC Life Hong KongcoreStrategic or Co-development Partner · 22 October 2024Strategic cooperation agreement signed October 22, 2024 enabling direct insurance settlement for Hong Kong insurance holders at Jiahui facilities in mainland China. The partnership targets residents frequently traveling between mainland China and Hong Kong, simplifying cross-border medical payments and enhancing healthcare accessibility.
• Massachusetts General Hospital (Harvard Medical School)coreStrategic or Co-development PartnerStrategic cooperation with Harvard Medical School affiliated Massachusetts General Hospital and its Cancer Center. Jiahui International Cancer Center is established as a strategic cooperation medical center with MGH. More than 20% of Jiahui doctors hold joint appointments with Mass General Hospital, bringing international expertise to China.
• 驯鹿生物 (IASO Biotherapeutics)coreStrategic or Co-development PartnerStrategic partnership for CAR-T therapy collaboration. Jiahui has partnered with驯鹿生物 to establish international-standard CAR-T treatment platform, sharing clinical experience, exchanging academic progress, and providing blood cancer education to medical staff.
• 复星凯特 (Fosun Kite)coreStrategic or Co-development PartnerPartnership with复星凯特 for CAR-T therapy products and treatment services. Jiahui has received CAR-T treatment center certification authorization for multiple indications including lymphoma and multiple myeloma.
• Shanghai Ruijin Blood Disease Medical AllianceminorStrategic or Co-development PartnerJiahui's hematology clinical team has established deep cooperative relationships with Shanghai Ruijin Hospital for blood disease treatment, achieving quality medical resource sharing and two-way patient management.
• Fudan University Huashan HospitalminorStrategic or Co-development PartnerPartnership with Fudan University affiliated Huashan Hospital for orthopedic collaboration. Dr. Lu Jiuzhou from Huashan Hospital collaborates with Jiahui on elbow joint disease diagnosis and treatment, having completed over 100 elbow surgeries together.
• Shanghai Shenhua Football ClubminorStrategic or Co-development PartnerOfficial medical partnership providing health management, sports injury prevention guidance, emergency treatment services, and medical support for players, coaches, and staff. Also supports blood donation initiatives.
• Global Medical Institution NetworkcoreStrategic or Co-development PartnerEstablished partnerships with 30+ global medical institutions including MD Anderson, Mayo Clinic, UCLA, Stanford, Cleveland Clinic, and leading hospitals in Japan, Thailand, Malaysia, and Hong Kong for international remote consultations and medical referrals.
• JMED (Jiahui Medical Research and Education Group)coreStrategic or Co-development PartnerInternal research and education arm of Jiahui Health, operating NEJM医学前沿 (NEJM Chinese version) and organizing medical education events including the International CAR-T Therapy Symposium.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• United Family Healthcare (和睦家医疗): Largest premium private hospital network in China, founded by Chindex. Operates JCI-accredited hospitals and clinics in Beijing, Shanghai, Guangzhou, and other Tier-1 cities, serving affluent Chinese and expatriate patients — the closest direct competitor to Jiahui International Hospital in positioning, international insurance coverage, and target patient base.
• Columbia China: Operates Columbia Jiaxing Kaiyi Hospital and other private hospitals in the Yangtze River Delta, with Columbia Pacific Management's international operating playbook. Directly comparable as a foreign-affiliated private hospital operator targeting insured and middle/upper-class Chinese patients in eastern China.

Broad incumbents

• Parkway Pantai / IHH Healthcare (China): Global hospital group operating Gleneagles and Pantai across Asia; in China focuses on premium foreign-managed hospitals. Comparable in international accreditation, insurance-direct billing, and inbound medical tourism positioning, though Jiahui is more domestically rooted.
• Raffles Medical Group: Asia-headquartered integrated private healthcare provider with hospitals and clinics across Singapore, China, and other markets. Comparable as a premium multi-site operator with strong international patient positioning in Asia.
• Bangkok Dusit Medical Services (BDMS) / Bangkok Hospital: Largest private hospital network in Thailand and a leading medical-tourism destination in Asia. Jiahui has an active exchange with BDMS's Wattanosoth Cancer Hospital — comparable as a regional cancer and inbound-patient competitor, particularly for Southeast Asian and Middle Eastern medical tourists.
• Mount Elizabeth / IHH (Singapore private hospitals): Flagship private tertiary hospitals in Singapore with strong Southeast Asian and international patient flow. Comparable as a tertiary-care, international-insurance-friendly hospital competing for the same regional premium medical-tourism pool Jiahui targets.

Regional players

• Phoenix Healthcare Group (凤凰医疗): One of China's largest private hospital groups, focused on hospital management and IOT (invest-operate-transfer) models with public hospitals. Comparable as a scaled private hospital operator in China, though primarily focused on public-hospital partnerships rather than premium international positioning.
• Hong Kong Sanatorium & Hospital: Leading private tertiary hospital in Hong Kong with strong international patient flow, particularly from mainland China. Comparable to Jiahui's HK clinic plus inbound Shanghai referrals as an alternative premium destination for Greater China and Southeast Asian patients.

Emerging players

• Yidu Tech (医渡科技) / We Doctor (微医): Leading Chinese digital health and online hospital platforms. Comparable as an emerging AI-and-data-enabled healthcare player; Jiahui's Unisound/SenseTime partnerships indicate a direction similar to where these players already operate, but with a physical-hospital base.
• Tencent Trusted Doctors (腾讯企鹅医生): Digital-first outpatient clinic network backed by Tencent. Comparable as a tech-enabled clinic platform targeting affluent Chinese patients in tier-1 cities, though lacking Jiahui's tertiary hospital, oncology, and IVF depth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jiahui Health